Ines De Pauw
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Cancer-related Molecular Pathways, Microtubule and mitosis dynamics, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor(2016)106 cited
- → Recent insights in the PI3K/Akt pathway as a promising therapeutic target in combination with EGFR‐targeting agents to treat head and neck squamous cell carcinoma(2021)61 cited
- → The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies(2021)57 cited
- → Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines(2018)48 cited
- → Enzymes Catalyzing the TCA- and Urea Cycle Influence the Matrix Composition of Biofilms Formed by Methicillin-Resistant Staphylococcus aureus USA300(2018)44 cited
- → Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status(2020)39 cited
- → Prognostic implications of cellular senescence in resected non-small cell lung cancer(2022)36 cited
- → In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53(2019)27 cited
- → The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines(2015)23 cited
- → A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein(2025)22 cited